Verve Therapeutics, Inc.
VERV
$6.16
-$0.06-0.97%
Headlines
4/27/2024
-
Tickeron - Stocks
4/26/2024
-
Tickeron - Stocks
4/25/2024
-
Zacks Investment Research
4/25/2024
-
Tickeron - Stocks
4/24/2024
-
Tickeron - Technical Analysis
4/23/2024
-
Tickeron - Stocks
4/20/2024
-
Tickeron - Stocks
4/19/2024
-
PR Newswire
4/19/2024
-
Tickeron - Stocks
4/18/2024
-
Tickeron - Stocks
4/18/2024
-
Zolmax
4/17/2024
-
Ticker Report
4/17/2024
-
Zolmax
4/11/2024
-
Ticker Report
4/9/2024
-
Stock Options Channel
4/8/2024
-
The Fly
4/7/2024
-
Ticker Report
4/6/2024
-
Fool.com Headlines
4/6/2024
-
Ticker Report
4/5/2024
-
Zolmax
4/4/2024
-
Ticker Report
4/4/2024
-
Zacks Investment Research
Filings
Tuesday, February 27, 2024
Sunday, December 31, 2023
Week of May 13 and 17 (est)
Price History
--
--
Corporate Info
617 603 0070
201 Brookline Avenue
Cambridge, MA 02215
Cambridge, MA 02215
Business Description
Verve Therapeutics, Inc., a clinical stage genetic medicines company, engages in developing gene editing medicines for patients to treat cardiovascular diseases in the United States. The...
more